The DOI matches its Crossref record; 478 of the 478 references it cites were found in a registry or an index.
Realistic expectations of prepulse inhibition in translational models for schizophrenia research
Open accessAbstract
Introduction Under specific conditions, a weak lead stimulus, or "prepulse", can inhibit the startling effects of a subsequent intense abrupt stimulus. This startle-inhibiting effect of the prepulse, termed "prepulse inhibition" (PPI), is widely used in translational models to understand the biology of brainbased inhibitory mechanisms and their deficiency in neuropsychiatric disorders. In 1981, four published reports with "prepulse inhibition" as an index term were listed on Medline; over the past 5 years, new published Medline reports with "prepulse inhibition" as an index term have appeared at a rate exceeding once every 2.7 days (n=678). Most of these reports focus on the use of PPI in translational models of impaired sensorimotor gating in schizophrenia. This rapid expansion and broad application of PPI as a tool for understanding schizophrenia has, at times, outpaced critical thinking and falsifiable hypotheses about the relative strengths vs. limitations of this measure.Objectives This review enumerates the realistic expectations for PPI in translational models for schizophrenia research, and provides cautionary notes for the future applications of this important research tool.Conclusion In humans, PPI is not "diagnostic"; levels of PPI do not predict clinical course, specific symptoms, or individual medication responses. In preclinical studies, PPI is valuable for evaluating models or model organisms relevant to schizophrenia, "mapping" neural substrates of deficient PPI in schizophrenia, and advancing the discovery and development of novel therapeutics. Across species, PPI is a reliable, robust quantitative phenotype that is useful for probing the neurobiology and genetics of gating deficits in schizophrenia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“normalizing PPI deficits in rodent models has enabled drug discovery for potential antipsychotic medications [371], some of which have proven successful in treating schizophrenia [368,372].”
From Reward circuitry dysfunction in psychiatric and neurodevelopmental disorders and genetic syndromes: animal models and clinical findings (2012) · cites this paper as [368]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–400 of 478
Wynn, J. K., Dawson, M. E., Schell, A. M., et al. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2003.10.018 · Cited by 87
Schneider, M., & Koch, M. (2005) · Experimental Neurology · doi:10.1016/j.expneurol.2005.04.014 · Cited by 86
Tanaka, K., Shintani, N., Hashimoto, H., Kawagishi, N., Ago, Y., Matsuda, T., Hashimoto, R., Kunugi, H., Yamamoto, A., Kawaguchi, C., et al. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.4376-05.2006 · Cited by 85
Abnormal neurodevelopment, neurosignaling and behaviour in Npas3-deficient mice
Brunskill, E. W., Ehrman, L. A., Williams, M. T., Klanke, J., Hammer, D., Schaefer, T. L., Sah, R., Il, G. W. D., Potter, S. S., & Vorhees, C. V. (2005) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2005.04291.x · Cited by 84
Meincke, U., Mörth, D., Voß, T., Thelen, B., Geyer, M. A., & Gouzoulis‐Mayfrank, E. (2004) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-004-0523-0 · Cited by 84
Reversal of phencyclidine-induced prepulse inhibition deficits by clozapine in monkeys
Linn, G. S., Negi, S., Gerum, S. V., & Javitt, D. C. (2003) · Psychopharmacology · doi:10.1007/s00213-003-1533-8 · Cited by 84
Garner, B., Wood, S. J., Pantelis, C., & van den Buuse, M. (2006) · Behavioural Brain Research · doi:10.1016/j.bbr.2006.10.020 · Cited by 83
Dirks, A., Groenink, L., Schipholt, M. L., van der Gugten, J., Hijzen, T. H., Geyer, M. A., & Olivier, B. (2002) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01323-3 · Cited by 83
Jones, C. K., Eberle, E. L., Shaw, D. B., et al. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.075887 · Cited by 83
Amphetamine Effects on Prepulse Inhibition Across-Species: Replication and Parametric Extension
Swerdlow, N. R., Stephany, N., Wasserman, L. C., Talledo, J., Shoemaker, J. M., & Auerbach, P. P. (2002) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300086 · Cited by 83
Self-citationPalmer, A. A., PRINTZ, D. J., Butler, P. D., Dulawa, S. C., & Printz, M. P. (2003) · Brain Research · doi:10.1016/j.brainres.2003.09.077 · Cited by 82
Powell, S. B., Geyer, M. A., Preece, M. A., Pitcher, L. K., Reynolds, G. P., & Swerdlow, N. R. (2003) · Neuroscience · doi:10.1016/s0306-4522(03)00122-2 · Cited by 82
Self-citationDUNCAN, G., MOY, S., LIEBERMAN, J., & KOLLER, B. (2006) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2006.09.017 · Cited by 82
Successful multi-site measurement of antisaccade performance deficits in schizophrenia
Radant, A. D., Dobie, D. J., Calkins, M. E., D, A. O. M., BRAFF, D. L., Cadenhead, K. S., Freedman, R., Green, M. F., Greenwood, T. A., Gur, R. E., et al. (2006) · Schizophrenia Research · doi:10.1016/j.schres.2006.08.010 · Cited by 81
Self-citationTadros, M. G., Khalifa, A. E., Abdel‐Naim, A. B., & Arafa, H. M. M. (2005) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2005.10.018 · Cited by 79
Disrupted sensorimotor gating due to mental fatigue: Preliminary evidence
van der Linden, D., Massar, S. A. A., Schellekens, A., Ellenbroek, B. A., & Verkes, R. (2006) · International Journal of Psychophysiology · doi:10.1016/j.ijpsycho.2006.04.001 · Cited by 79
Deficits in social behavior and sensorimotor gating in mice lacking phospholipase Cβ1
Koh, H. ‐., Kim, D., Lee, J., Lee, S., & Shin, H. (2007) · Genes Brain & Behavior · doi:10.1111/j.1601-183x.2007.00351.x · Cited by 78
Yamashita, M., Fukushima, S., Shen, H.-W., Hall, F. S., Uhl, G. R., Numachi, Y., Kobayashi, H., & Sora, I. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301009 · Cited by 77
Rueter, L. E., Ballard, M. E., Gallagher, K. B., Basso, A. M., Curzon, P., & Kohlhaas, K. L. (2004) · Psychopharmacology · doi:10.1007/s00213-004-1897-4 · Cited by 77
Klejbor, I., Myers, J. M., Hausknecht, K., Corso, T. D., Gambino, A. S., Moryś, J., Maher, P., Hard, R., Richards, J. C., Stachowiak, E., et al. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03754.x · Cited by 76
Nagai, H., Egashira, N., Sano, K., Ogata, A., Mizuki, A., Mishima, K., Iwasaki, K., Shoyama, Y., Nishimura, R., & Fujiwara, M. (2006) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2006.05.018 · Cited by 75
Wynn, J. K., Green, M. F., Sprock, J., Light, G. A., Widmark, C., Reist, C., Erhart, S. M., Marder, S. R., Mintz, J., & BRAFF, D. L. (2007) · Schizophrenia Research · doi:10.1016/j.schres.2007.05.039 · Cited by 74
Self-citationPrepulse startle deficit in the Brown Norway rat: A potential genetic model.
Palmer, A. A., Dulawa, S. C., Mottiwala, A. A., et al. (2000) · Behavioral Neuroscience · doi:10.1037/0735-7044.114.2.374 · Cited by 73
Female schizophrenia patients have prepulse inhibition deficits
BRAFF, D. L., Light, G. A., Ellwanger, J., Sprock, J., & Swerdlow, N. R. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.12.030 · Cited by 72
Self-citationSchneider, M., Drews, E., & Koch, M. (2005) · Behavioural Pharmacology · doi:10.1097/00008877-200509000-00018 · Cited by 72
Kelly, M. P., Isiegas, C., Cheung, Y.-F., Tokarczyk, J., Yang, X., Esposito, M. F., Rapoport, D. A., Fabian, S., Siegel, S. J., Wand, G. S., et al. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301099 · Cited by 72
Perry, W., Feifel, D., Minassian, A., Bhattacharjie, I., & BRAFF, D. L. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.8.1375 · Cited by 71
Self-citationGogos, A., & van den Buuse, M. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.061432 · Cited by 71
Antipsychotic Effects on Prepulse Inhibition in Normal ‘Low Gating’ Humans and Rats
Swerdlow, N. R., Talledo, J., Sutherland, A. N., Nagy, D., & Shoemaker, J. M. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301043 · Cited by 70
Self-citationYee, B. K., Russig, H. D., & Feldon, J. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300323 · Cited by 70
Isolation rearing of mice induces deficits in prepulse inhibition of the startle response
Varty, G. B., Powell, S. B., Masten, V. L., Buell, M. R., & Geyer, M. A. (2006) · Behavioural Brain Research · doi:10.1016/j.bbr.2005.11.025 · Cited by 70
Isolation rearing-induced disruption of prepulse inhibition
Weiss, I. C., Feldon, J., & Domeney, A. M. (1999) · Behavioural Pharmacology · doi:10.1097/00008877-199903000-00003 · Cited by 69
Feifel, D., Melendez, G., & Shilling, P. D. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300378 · Cited by 69
Effect of antipsychotic treatment on the prepulse inhibition deficit of mGluR5 knockout mice
Brody, S. A., Conquet, F., & Geyer, M. A. (2004) · Psychopharmacology · doi:10.1007/s00213-003-1635-3 · Cited by 68
Withdrawal from chronic nicotine in adolescent and adult rats
Wilmouth, C. E., & SPEAR, L. P. (2006) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2006.10.021 · Cited by 68
Lamotrigine prevents ketamine but not amphetamine-induced deficits in prepulse inhibition in mice
Brody, S. A., Geyer, M. A., & Large, C. H. (2003) · Psychopharmacology · doi:10.1007/s00213-003-1421-2 · Cited by 68
Browman, K. E., Komater, V. A., Curzon, P., Rueter, L. E., Hancock, A. A., Decker, M. W., & Fox, G. B. (2003) · Behavioural Brain Research · doi:10.1016/j.bbr.2003.11.001 · Cited by 68
Effects of neonatal lesions of the medial prefrontal cortex on adult rat behaviour
Schwabe, K., Enkel, T., Klein, S., Schütte, M., & Koch, M. (2003) · Behavioural Brain Research · doi:10.1016/j.bbr.2003.10.030 · Cited by 68
Buisman‐Pijlman, F. T. A., Herremans, A. H. J., van de Kieft, J. G., Kruse, C. G., & van Ree, J. M. (2003) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(03)00040-3 · Cited by 67
NEUROBEHAVIORAL AND IMMUNOLOGICAL CONSEQUENCES OF PRENATAL IMMUNE ACTIVATION IN RATS
Borrell, J. I. (2008) · Schizophrenia Research · doi:10.1016/s0920-9964(08)70050-1 · Cited by 66
The effects of dopamine agonists on prepulse inhibition in healthy men depend on baseline PPI values
Bitsios, P., Giakoumaki, S. G., & Frangou, S. (2005) · Psychopharmacology · doi:10.1007/s00213-005-0056-x · Cited by 66
Effect of treatment status on prepulse inhibition of acoustic startle in schizophrenia
Duncan, E., Szilagyi, S., Efferen, T. R., Schwartz, M. P., Parwani, A., Chakravorty, S., Madonick, S. H., Kunzova, A., Harmon, J. W., Angrist, B., et al. (2003) · Psychopharmacology · doi:10.1007/s00213-002-1372-z · Cited by 65
Zhang, W., Bast, T., & Feldon, J. (2002) · Behavioral Neuroscience · doi:10.1037//0735-7044.116.1.72 · Cited by 65
Daenen, E. W. P. M., Wolterink, G., Heyden, J. A. V. D., Kruse, C. G., & van Ree, J. M. (2003) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(03)00007-5 · Cited by 65
Heldt, S. A., & Ressler, K. J. (2006) · Brain Research · doi:10.1016/j.brainres.2005.12.053 · Cited by 65
Amphetamine-induced disruption of prepulse inhibition in mice with reduced NMDA receptor function.
Moy, S., Perez, A., Koller, B., & Duncan, G. (2006) · Brain Research · doi:10.1016/j.brainres.2006.03.073 · Cited by 65
Caine, S. B., Humby, T., Robbins, T. W., & Everitt, B. J. (2001) · Behavioral Neuroscience · doi:10.1037/0735-7044.115.4.880 · Cited by 65
Ballmaier, M., Bortolato, M., Rizzetti, M. C., Zoli, M., Gessa, G., Heinz, A., & Spano, P. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301344 · Cited by 65
Vollenweider, F. X., Barro, M., Csomor, P., & Feldon, J. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.03.058 · Cited by 65
Hohnadel, E. J., Bouchard, K., & Terry, A. V. (2006) · Neuropharmacology · doi:10.1016/j.neuropharm.2006.08.025 · Cited by 65
Reduced startle habituation and prepulse inhibition in mice lacking the adenosine A2A receptor
Wang, J. H., Short, J. L., Ledent, C. A., Lawrence, A. J., & van den Buuse, M. (2003) · Behavioural Brain Research · doi:10.1016/s0166-4328(03)00036-6 · Cited by 64
Sobin, C. A., Kiley‐Brabeck, K., & Karayiorgou, M. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001609 · Cited by 64
Prepulse Inhibition Deficits in GAD65 Knockout Mice and the Effect of Antipsychotic Treatment
Heldt, S. A., Green, A. M., & Ressler, K. J. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300468 · Cited by 63
Increased alcohol drinking in isolate-housed alcohol-preferring rats.
Ehlers, C. L., Walker, B. M., Pian, J. P., Roth, J., & Slawecki, C. J. (2007) · Behavioral Neuroscience · doi:10.1037/0735-7044.121.1.111 · Cited by 63
Swerdlow, N. R., Sprock, J., Light, G. A., Cadenhead, K. S., Calkins, M. E., Dobie, D. J., Freedman, R., Green, M. F., Greenwood, T. A., Gur, R. E., et al. (2007) · Schizophrenia Research · doi:10.1016/j.schres.2007.01.012 · Cited by 63
Self-citationTakahashi, K., Nagai, T., Kamei, H., Maeda, K., Matsuya, T., Arai, S., Mizoguchi, H., Yoneda, Y., Nabeshima, T., Takuma, K., et al. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.06.035 · Cited by 63
Heritable differences in the dopaminergic regulation of sensorimotor gating
Swerdlow, N. R., Shoemaker, J. M., Auerbach, P. P., Pitcher, L., Goins, J., & Platten, A. (2003) · Psychopharmacology · doi:10.1007/s00213-003-1480-4 · Cited by 62
Self-citationEells, J. B., Misler, J. A., & Nikodem, V. M. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2005.12.065 · Cited by 62
Bast, T., Zhang, W.-N., Heidbreder, C. A., & Feldon, J. (2001) · Neuroscience · doi:10.1016/s0306-4522(00)00589-3 · Cited by 61
Bowers, B. J., McClure‐Begley, T. D., Keller, J. J., Paylor, R. E., Collins, A. C., & Wehner, J. M. (2005) · Alcoholism Clinical and Experimental Research · doi:10.1097/01.alc.0000156116.40817.a2 · Cited by 61
Early Auditory Sensory Processing Deficits in Mouse Mutants with Reduced NMDA Receptor Function
Bickel, S., Lipp, H., & Umbricht, D. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301536 · Cited by 61
Feifel, D., & Priebe, K. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01100-3 · Cited by 60
Effects of the 5-HT6 receptor antagonist, SB-271046, in animal models for schizophrenia
Pouzet, B., Didriksen, M., & Arnt, J. (2002) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(01)00743-2 · Cited by 60
Cadenhead, K. S. (2002) · Psychiatric Clinics of North America · doi:10.1016/s0193-953x(02)00021-7 · Cited by 60
Bakshi, V. P., Geyer, M. A., Taaid, N., & Swerdlow, N. R. (1995) · Behavioural Pharmacology · doi:10.1097/00008877-199512000-00005 · Cited by 59
Self-citationTaniguchi, T., Doe, N., Matsuyama, S., Kitamura, Y., Mori, H., Saito, N., & Tanaka, C. (2005) · FEBS Letters · doi:10.1016/j.febslet.2005.09.047 · Cited by 59
Burne, T. H. J., Feron, F. P., Brown, J., Eyles, D. W., McGrath, J. J., & Mackay‐Sim, A. (2004) · Physiology & Behavior · doi:10.1016/j.physbeh.2004.03.004 · Cited by 59
Swerdlow, N. R., Geyer, M. A., Shoemaker, J. M., Light, G. A., BRAFF, D. L., Stevens, K. E., Sharp, R. F., Breier, M. R., Neary, A. C., & Auerbach, P. P. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300841 · Cited by 59
Self-citationAuclair, A. L., Kleven, M. S., Besnard, J., et al. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301015 · Cited by 59
Early adversity alters attention and locomotion in adult Sprague-Dawley rats.
Burton, C. L., Lovic, V., & Fleming, A. S. (2006) · Behavioral Neuroscience · doi:10.1037/0735-7044.120.3.665 · Cited by 59
Prepulse inhibition in patients with non-psychotic major depressive disorder
Perry, W. (2003) · Journal of Affective Disorders · doi:10.1016/s0165-0327(03)00157-5 · Cited by 58
Sakaue, M., Ago, Y., Baba, A., & Matsuda, T. (2003) · Psychopharmacology · doi:10.1007/s00213-003-1515-x · Cited by 57
Nagel, J., Schladebach, H., Koch, M., Schwienbacher, I., Müller, C. E., & Hauber, W. (2003) · Synapse · doi:10.1002/syn.10240 · Cited by 57
Temporal course of emotional startle modulation in schizophrenia patients
Volz, M. J., Hamm, A. O., Kirsch, P., & Rey, E.-R. (2003) · International Journal of Psychophysiology · doi:10.1016/s0167-8760(03)00100-4 · Cited by 56
Prepulse inhibition in rats with temporary inhibition/inactivation of ventral or dorsal hippocampus
Zhang, W.-N., Bast, T., & Feldon, J. (2002) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(02)00936-x · Cited by 56
Beglopoulos, V., Sallaz, M., Rohlmann, A., Piechotta, K., Ahmad, M., Montag, D., & Missler, M. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.16.7278-7288.2005 · Cited by 56
Risterucci, C., Jeanneau, K., Schöppenthau, S., Bielser, T., Künnecke, B., von Kienlin, M., & Moreau, J. (2005) · Psychopharmacology · doi:10.1007/s00213-005-2204-8 · Cited by 56
Depoortère, R., Auclair, A. L., Bardin, L., Slot, L. A. B., Kleven, M. S., Colpaert, F. C., Vacher, B., & Newman‐Tancredi, A. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707160 · Cited by 55
Suemaru, K., Yasuda, K., Umeda, K., Araki, H., Shibata, K., Choshi, T., Hibino, S., & Gomita, Y. (2004) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705855 · Cited by 54
Semenova, S., Geyer, M. A., Sutcliffe, J. G., Markou, A., & Hedlund, P. B. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.12.011 · Cited by 53
Reversal of isolation-rearing-induced PPI deficits by an α7 nicotinic receptor agonist
Cilia, J., Cluderay, J. E., Robbins, M. J., Reavill, C., Southam, E., Kew, J. N. C., & Jones, D. N. C. (2005) · Psychopharmacology · doi:10.1007/s00213-005-0069-5 · Cited by 53
Zhang, W., Bast, T., & Feldon, J. (2002) · Behavioral Neuroscience · doi:10.1037/0735-7044.116.1.72 · Cited by 53
Lähdesmäki, J., Sallinen, J., MacDonald, E., & Scheinin, M. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300428 · Cited by 53
Diederich, K., & Koch, M. (2004) · Psychopharmacology · doi:10.1007/s00213-004-2052-y · Cited by 53
Klamer, D., Engel, J. A., & Svensson, L. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.09.042 · Cited by 53
Kusljic, S., Copolov, D., & van den Buuse, M. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300277 · Cited by 53
Effects of copper metabolism on neurological functions in Wistar and Wilson’s disease model rats
Fujiwara, N., Iso, H., Kitanaka, N., et al. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.08.139 · Cited by 53
Hauser, J., Feldon, J., & Pryce, C. R. (2006) · Behavioural Brain Research · doi:10.1016/j.bbr.2006.07.026 · Cited by 52
Iso, H., Shimoda, S., & Matsuyama, T. (2007) · Behavioural Brain Research · doi:10.1016/j.bbr.2007.01.025 · Cited by 52
Schwabe, K., & Koch, M. (2003) · Neuroscience Letters · doi:10.1016/j.neulet.2003.10.028 · Cited by 51
Takeuchi, T., Kiyama, Y., Nakamura, K., Tsujita, M., Matsuda, I., Mori, H., Munemoto, Y., Kuriyama, H., Natsume, R., Sakimura, K., et al. (2001) · European Journal of Neuroscience · doi:10.1046/j.0953-816x.2001.01620.x · Cited by 51
Swerdlow, N. R., Bongiovanni, M. J., Tochen, L. S., & Shoemaker, J. M. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0374-7 · Cited by 51
Self-citationActivation of GABAB receptors reverses spontaneous gating deficits in juvenile DBA/2J mice
Bortolato, M., Frau, R., Orrù, M., et al. (2007) · Psychopharmacology · doi:10.1007/s00213-007-0845-5 · Cited by 51
Kinkead, B. L., Dobner, P. R., Egnatashvili, V., et al. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.087437 · Cited by 51
Duncan, E., Szilagyi, S., Schwartz, M. P., Kunzova, A., Negi, S., Efferen, T. R., Peselow, E. D., Chakravorty, S., Stephanides, M., Harmon, J. W., et al. (2003) · Psychiatry Research · doi:10.1016/s0165-1781(03)00161-6 · Cited by 50
Associative and motor learning in 12-month-old transgenic APP+PS1 mice
Ewers, M., Morgan, D., Gordon, M. N., & Woodruff‐Pak, D. S. (2005) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.05.019 · Cited by 50
Powell, S. B., Swerdlow, N. R., Pitcher, L., & Geyer, M. A. (2002) · Physiology & Behavior · doi:10.1016/s0031-9384(02)00817-x · Cited by 49
Self-citationMurphy, C. A., Fend, M., Russig, H. D., et al. (2001) · Behavioral Neuroscience · doi:10.1037//0735-7044.115.6.1247 · Cited by 49
Barr, A. M., Powell, S. B., Markou, A., & Geyer, M. A. (2006) · Neuropharmacology · doi:10.1016/j.neuropharm.2006.04.004 · Cited by 49
Grobin, A. C., Gizerian, S. S., Lieberman, J. A., & Morrow, A. L. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2005.12.026 · Cited by 49
Irintchev, A., Koch, M., Needham, L. K., et al. (2004) · Brain Research · doi:10.1016/j.brainres.2004.09.042 · Cited by 49
Dirks, A., Groenink, L., Westphal, K. G. C., Olivier, J. D. A., Verdouw, P. M., van der Gugten, J., Geyer, M. A., & Olivier, B. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300256 · Cited by 49
Kumari, V., Das, M., Hodgins, S., Zachariah, E., Barkataki, I., Howlett, M. P., & Sharma, T. (2004) · Behavioural Brain Research · doi:10.1016/j.bbr.2004.08.021 · Cited by 48
Lipina, T. V., Weiss, K. C., & Roder, J. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301191 · Cited by 48
Egashira, N., Tanoue, A., Higashihara, F., Fuchigami, H., Sano, K., 三島, 健., Fukue, Y., Nagai, H., Takano, Y., Tsujimoto, G., et al. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300784 · Cited by 48
Takahashi, M., Kakita, A., Futamura, T., Watanabe, Y., Mizuno, M., Sakimura, K., Ċastrén, E., Nabeshima, T., Someya, T., & Nawa, H. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04106.x · Cited by 48
An Investigation of the Efficacy of Mood Stabilizers in Rodent Models of Prepulse Inhibition
Ong, J. C., Brody, S. A., Large, C. H., & Geyer, M. A. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.090845 · Cited by 48
Choy, K. H. C., & van den Buuse, M. (2008) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2007.03.011 · Cited by 47
Prefrontal D1 and ventral hippocampal N-methyl-d-aspartate regulation of startle gating in rats
Shoemaker, J. M., Marie, R. L. S., Bongiovanni, M. J., Neary, A. C., Tochen, L. S., & Swerdlow, N. R. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2005.06.054 · Cited by 47
Self-citationMinassian, A., Feifel, D., & Perry, W. (2006) · Schizophrenia Research · doi:10.1016/j.schres.2006.08.006 · Cited by 46
Shilling, P. D., Richelson, E., & Feifel, D. (2003) · Behavioural Brain Research · doi:10.1016/s0166-4328(03)00037-8 · Cited by 45
Murphy, C. A., Fend, M., Russig, H. D., et al. (2001) · Behavioral Neuroscience · doi:10.1037/0735-7044.115.6.1247 · Cited by 45
Sensorimotor gating, orienting and social perception in schizophrenia
Wynn, J. K., Sergi, M. J., Dawson, M. E., Schell, A. M., & Green, M. F. (2004) · Schizophrenia Research · doi:10.1016/j.schres.2004.07.013 · Cited by 44
Recovery curves of the blink reflex during wakefulness and sleep
Kimura, J., & Harada, O. (1976) · Journal of Neurology · doi:10.1007/bf00312869 · Cited by 44
Cilia, J., Hatcher, P. D., Reavill, C., & Jones, D. N. C. (2007) · Journal of Psychopharmacology · doi:10.1177/0269881107077718 · Cited by 44
Thomsen, M., Wörtwein, G., Fink‐Jensen, A., Woldbye, D. P. D., Wess, J., & Caine, S. B. (2007) · Psychopharmacology · doi:10.1007/s00213-006-0682-y · Cited by 43
Prepulse inhibition of acoustic startle in aromatase knock‐out mice: effects of age and gender
van den Buuse, M., Simpson, E. R., & Jones, M. E. E. (2003) · Genes Brain & Behavior · doi:10.1034/j.1601-183x.2003.00014.x · Cited by 43
Dai, H., OKUDA, H., Iwabuchi, K., Sakurai, E., Chen, Z., Kato, M., Iinuma, K., & Yanai, K. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1316.032 · Cited by 43
Bortolato, M., Frau, R., Aru, G. N., Orr�, M., & Gessa, G. L. (2004) · Psychopharmacology · doi:10.1007/s00213-003-1589-5 · Cited by 43
Neonatal impact of leukemia inhibitory factor on neurobehavioral development in rats
Watanabe, Y., Hashimoto, S., Kakita, A., Takahashi, H., Ko, J., Mizuno, M., Someya, T., Patterson, P. H., & Nawa, H. (2004) · Neuroscience Research · doi:10.1016/j.neures.2003.12.001 · Cited by 43
Hsieh, M. H., Swerdlow, N. R., & BRAFF, D. L. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.07.032 · Cited by 42
Self-citationDepoortère, R., Bardin, L., Auclair, A. L., Kleven, M. S., Prinssen, E. P. M., Colpaert, F. C., Vacher, B., & Newman‐Tancredi, A. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707159 · Cited by 42
Pletnikov, M. V., Rubin, S. A., Vogel, M. W., Moran, T. H., & Carbone, K. M. (2002) · Brain Research · doi:10.1016/s0006-8993(02)02723-3 · Cited by 42
Long-term effects of developmental PCP administration on sensorimotor gating in male and female rats
Rasmussen, B. A., O’Neil, J. N., Manaye, K. F., et al. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0584-z · Cited by 41
Sills, T. L. (1999) · Brain Research Bulletin · doi:10.1016/s0361-9230(99)00036-2 · Cited by 41
Kumari, V., Fannon, D. G., Sumich, A. L., & Sharma, T. (2007) · Psychiatry Research · doi:10.1016/j.psychres.2006.09.013 · Cited by 41
Sensitivity to drug effects on prepulse inhibition in inbred and outbred rat strains
Swerdlow, N. R., Shoemaker, J. M., Crain, S. K., et al. (2003) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2003.11.008 · Cited by 41
Self-citationKappa Opioid Receptor Activation Disrupts Prepulse Inhibition of the Acoustic Startle in Rats
Bortolato, M., Aru, G. N., Frau, R., Orrù, M., Fà, M., Manunta, M., Puddu, M., Mereu, G., & Gessa, G. L. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.02.030 · Cited by 41
Stevenson, C. W., & Gratton, A. P. (2004) · Psychopharmacology · doi:10.1007/s00213-004-1879-6 · Cited by 41
Brody, S. A., & Geyer, M. A. (2004) · Neurotoxicity Research · doi:10.1007/bf03033300 · Cited by 40
Ma, J., Bixia Shen, A., Rajakumar, N., & Leung, L.-W. S. (2004) · Behavioural Brain Research · doi:10.1016/j.bbr.2004.04.010 · Cited by 40
Rosa, M. L. N. M., Silva, R. C. B., Moura-de-Carvalho, F. T., Brandão, M. L., Guimarães, F. S., & Bel, E. A. D. (2005) · Brazilian Journal of Medical and Biological Research · doi:10.1590/s0100-879x2005001100018 · Cited by 40
Rosa, M. L. N. M., Nobre, M. J., de Oliveira, A. R., & Brandão, M. L. (2005) · Neuropsychobiology · doi:10.1159/000085820 · Cited by 40
Kedzior, K. K., & Martin-Iverson, M. T. (2007) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.01.032 · Cited by 39
Park, W., Jeong, D.-Y., Cho, H., Lee, S. J., Cha, M. Y., Pae, A. N., Choi, K. I., Koh, H. Y., & Kong, J. Y. (2005) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2005.09.006 · Cited by 39
Boeckler, F. M., Russig, H. D., Zhang, W., L�ber, S., Schetz, J. A., bner, H. H., Ferger, B., Gmeiner, P., & Feldon, J. (2004) · Psychopharmacology · doi:10.1007/s00213-004-1782-1 · Cited by 39
van den Buuse, M., Morris, M. J., Chavez, C. A., Martin, S., & Wang, J. (2004) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705511 · Cited by 39
Pothuizen, H. H. J., Jongen‐Rêlo, A. L., & Feldon, J. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300643 · Cited by 38
Jongen‐Rêlo, A. L., Leng, A., Lüber, M., Pothuizen, H. H. J., Weber, L., & Feldon, J. (2003) · Behavioural Brain Research · doi:10.1016/s0166-4328(03)00228-6 · Cited by 38
Shilling, P. D., Marie, R. L. S., Shoemaker, J. M., & Swerdlow, N. R. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.10.015 · Cited by 38
Self-citationSchizophrenia-like behavioral changes after partial hippocampal kindling
Ma, J., & Leung, L.-W. S. (2003) · Brain Research · doi:10.1016/j.brainres.2003.11.004 · Cited by 38
Fejgin, K., Safonov, S., Pålsson, E., et al. (2007) · Psychopharmacology · doi:10.1007/s00213-006-0658-y · Cited by 37
Salum, C., Guimarães, F. S., Brandão, M. L., & Bel, E. A. D. (2006) · Psychopharmacology · doi:10.1007/s00213-005-0277-z · Cited by 37
Reinforcing Mood Effects of Alcohol in Coping and Enhancement Motivated Drinkers
Wilkie, H., & Stewart, S. H. (2005) · Alcoholism Clinical and Experimental Research · doi:10.1097/01.alc.0000163498.21044.cb · Cited by 37
Howland, J. G., Hannesson, D. K., Barnes, S. J., & Phillips, A. G. (2006) · Behavioural Brain Research · doi:10.1016/j.bbr.2006.11.009 · Cited by 37
Fitting, S., Booze, R. M., & Mactutus, C. F. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.105742 · Cited by 37
Prepulse inhibition of perceived stimulus intensity: paradigm assessment
Swerdlow, N. R., Stephany, N., Talledo, J., Light, G. A., BRAFF, D. L., Baeyens, D., & Auerbach, P. P. (2004) · Biological Psychology · doi:10.1016/j.biopsycho.2004.07.002 · Cited by 36
Self-citationPhencyclidine‐Induced Behaviour in Mice Prevented by Methylene Blue
Klamer, D., Engel, J. A., & Svensson, L. (2004) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/j.1742-7843.2004.pto940203.x · Cited by 36
Culm, K. E., Lugo‐Escobar, N., Hope, B. T., & Hammer, R. P. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300483 · Cited by 36
McCool, M. F., Varty, G. B., Vecchio, R. A. D., Kazdoba, T. M., Parker, E. M., Hunter, J. C., & Hyde, L. A. (2003) · Brain Research · doi:10.1016/j.brainres.2003.09.025 · Cited by 36
Spielewoy, C., & Markou, A. (2004) · Behavior Genetics · doi:10.1023/b:bege.0000017878.75206.fd · Cited by 35
Sensorimotor Gating Deficits in Transgenic Mice Expressing a Constitutively Active Form of Gsα
Gould, T. J., Bizily, S. P., Tokarczyk, J., Kelly, M. P., Siegel, S. J., Kanes, S., & Abel, T. G. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300309 · Cited by 35
Kusljic, S., & van den Buuse, M. (2004) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2004.03804.x · Cited by 35
Andreasen, J. T., Andersen, K. K., Nielsen, E. Ø., Mathiasen, L., & Mirza, N. R. (2005) · Behavioural Brain Research · doi:10.1016/j.bbr.2005.08.023 · Cited by 35
Genetic Alteration of Anxiety and Stress-Like Behavior in Mice Lacking CaMKIV
Shum, F. W. F., Ko, S. W., Lee, Y., Kaang, B., & Zhuo, M. (2005) · Molecular Pain · doi:10.1186/1744-8069-1-22 · Cited by 35
Brody, S. A., Nakanishi, N., Tu, S., Lipton, S. A., & Geyer, M. A. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.01.024 · Cited by 34
Heresco‐Levy, U., Bar, G., Levin, R., et al. (2007) · Schizophrenia Research · doi:10.1016/j.schres.2006.12.003 · Cited by 34
Jaworski, D. M., Boone, J. Q., Caterina, J. J., Soloway, P. D., & Falls, W. A. (2005) · Brain Research · doi:10.1016/j.brainres.2005.05.057 · Cited by 34
Hazlett, E. A., Levine, J., Buchsbaum, M. S., Silverman, J. M., New, A. S., Sevin, E. M., Maldari, L. A., & Siever, L. J. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.9.1621 · Cited by 34
Sensorimotor gating in manic and mixed episode bipolar disorder
Carroll, C. A., Vohs, J. L., O’Donnell, B. F., Shekhar, A., & Hetrick, W. P. (2007) · Bipolar Disorders · doi:10.1111/j.1399-5618.2007.00415.x · Cited by 34
Reduced anxiety- and depression-like behaviors in Emx1 homozygous mutant mice
Cao, B., & Li, Y. (2002) · Brain Research · doi:10.1016/s0006-8993(02)02461-7 · Cited by 34
Normal levels of prepulse inhibition in the euthymic phase of bipolar disorder
Barrett, S., Kelly, C. J., Watson, D. R., Bell, R., & King, D. J. (2005) · Psychological Medicine · doi:10.1017/s0033291705005702 · Cited by 34
Howland, J. G., MacKenzie, E. M., Yim, T. T.-L., Taepavarapruk, P., & Phillips, A. G. (2003) · Behavioural Brain Research · doi:10.1016/j.bbr.2003.10.001 · Cited by 33
Dai, H., Okuda, T., Sakurai, E., Kuramasu, A., Kato, M., Jia, F., Xu, A., Iinuma, K., Sato, I., & Yanai, K. (2005) · Psychopharmacology · doi:10.1007/s00213-005-0203-4 · Cited by 33
CRF1 Not Glucocorticoid Receptors Mediate Prepulse Inhibition Deficits in Mice Overexpressing CRF
Groenink, L., Dirks, A., Verdouw, P. M., de Graaff, M., Peeters, B. W. M. M., Millan, M. J., & Olivier, B. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.06.002 · Cited by 33
An investigation of prepulse inhibition in pediatric bipolar disorder
Rich, B. A., Vinton, D. T., Grillon, C., Bhangoo, R. K., & Leibenluft, E. (2005) · Bipolar Disorders · doi:10.1111/j.1399-5618.2005.00183.x · Cited by 33
Kumari, V., Ettinger, U., Crawford, T. J., Zachariah, E., & Sharma, T. (2004) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2004.08.007 · Cited by 33
Independent Domains of Inhibitory Gating in Schizophrenia and the Effect of Stimulus Interval
Hong, L. E., Summerfelt, A. T., Wonodi, I., Adami, H. M., Buchanan, R. W., & Thaker, G. K. (2007) · American Journal of Psychiatry · doi:10.1176/ajp.2007.164.1.61 · Cited by 33
Neurotensin agonists block the prepulse inhibition deficits produced by a 5-HT2A and an ?1 agonist
Shilling, P. D., Melendez, G., Priebe, K., et al. (2004) · Psychopharmacology · doi:10.1007/s00213-004-1835-5 · Cited by 33
Fitting, S., Booze, R. M., & Mactutus, C. F. (2006) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2006.02.001 · Cited by 33
Impaired sensorimotor gating in schizophrenia with deficit and with nondeficit syndrome
Ludewig, K., & Vollenweider, F. X. (2002) · Swiss Medical Weekly · doi:10.4414/smw.2002.09873 · Cited by 33
Reduced prepulse inhibition in rats with entorhinal cortex lesions
Goto, K., Ueki, A., Iso, H., & Morita, Y. (2002) · Behavioural Brain Research · doi:10.1016/s0166-4328(02)00039-6 · Cited by 32
van den Buuse, M., & Gogos, A. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.113084 · Cited by 31
Swerdlow, N. R., Wasserman, L. C., Talledo, J., Casas, R. N., Bruins, P., & Stephany, N. (2002) · Biological Psychology · doi:10.1016/s0301-0511(02)00090-x · Cited by 30
Self-citationSwerdlow, N. R., Krupin, A. S., Bongiovanni, M. J., et al. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300877 · Cited by 30
Self-citationSensorimotor Gating and Dopamine Function in Postpartum Rats
Byrnes, E. M., Bridges, R. S., Scanlan, V. F., Babb, J. A., & BYRNES, J. J. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301222 · Cited by 30
Prestimulus effects on startle magnitude: Sensory or motor?
Swerdlow, N. R., Shoemaker, J. M., Stephany, N., Wasserman, L. C., Ro, H. J., & Geyer, M. A. (2002) · Behavioral Neuroscience · doi:10.1037//0735-7044.116.4.672 · Cited by 30
Self-citationFitting, S., Booze, R. M., Hasselrot, U., & Mactutus, C. F. (2006) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2006.04.014 · Cited by 30
Swerdlow, N. R., Shoemaker, J. M., Kuczenski, R. T., Bongiovanni, M. J., Neary, A. C., Tochen, L. S., & Marie, R. L. S. (2006) · Neuroscience Letters · doi:10.1016/j.neulet.2006.03.060 · Cited by 29
Self-citationSpooren, W. P. J. M., Mombereau, C., Maco, M., Gill, R., Kemp, J. A., Ozmen, L., Nakanishi, S., & Higgins, G. A. (2004) · Psychopharmacology · doi:10.1007/s00213-004-1785-y · Cited by 29
Schwienbacher, I., Fendt, M., Hauber, W., & Koch, M. (2002) · European Journal of Pharmacology · doi:10.1016/s0014-2999(02)01622-9 · Cited by 29
Cáceda, R., Kinkead, B. L., Owens, M. J., & Nemeroff, C. B. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.4282-05.2005 · Cited by 29
Freudenberg, F., Dieckmann, M., Winter, S., Koch, M., & Schwabe, K. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2007.06.034 · Cited by 29
Peak, H. (1939) · Journal of Experimental Psychology · doi:10.1037/h0063056 · Cited by 29
Czyrak, A., Maćkowiak, M., Chocyk, A., Fijał, K., Gądek-Michalska, A., & Wędzony, K. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300165 · Cited by 29
Shishkina, G. T., Kalinina, T. S., Popova, N. K., & Дыгало, Н. Н. (2004) · Behavioral Neuroscience · doi:10.1037/0735-7044.118.6.1285 · Cited by 28
Ballmaier, M., Casamenti, F., Scali, C., et al. (2002) · Neuroscience · doi:10.1016/s0306-4522(02)00234-8 · Cited by 28
van den Buuse, M., Martin, S., Brosda, J., Leck, K. J., Matthaei, K. I., & Hendry, I. A. (2005) · Psychopharmacology · doi:10.1007/s00213-005-0181-6 · Cited by 28
The role of hippocampal dopamine receptors in prepulse inhibition
Ellenbroek, B. A., Lubbers, L. J., & Cools, A. R. (2002) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2002.01948.x · Cited by 28
Ellenbroek, B. A., Liégeois, J., Bruhwyler, J., et al. (2001) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29392-7 · Cited by 28
Gizerian, S. S., Moy, S. S., Lieberman, J. A., & Grobin, A. C. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0360-0 · Cited by 27
Zhang, M., Ballard, M. E., UNGER, L., Haupt, A., GROSS, G., Decker, M. W., Drescher, K. U., & Rueter, L. E. (2007) · Behavioural Brain Research · doi:10.1016/j.bbr.2007.04.021 · Cited by 27
Brea, J. M., Castro, M., Loza, M. I., Masaguer, C. F., Raviña, E., Dezi, C., Pastor, M., Sanz, F., Cabrero-Castel, A., Galán-Rodríguez, B., et al. (2006) · Neuropharmacology · doi:10.1016/j.neuropharm.2006.03.021 · Cited by 27
The reelin receptors VLDLR and ApoER2 regulate sensorimotor gating in mice
Barr, A. M., Fish, K. N., & Markou, A. (2007) · Neuropharmacology · doi:10.1016/j.neuropharm.2006.11.011 · Cited by 26
Schmitt, A., Fendt, M., Zink, M., Ebert, U., Starke, M., Berthold, M., Herb, A., Petroianu, G. A., Falkai, P., & Henn, F. A. (2006) · Journal of Neural Transmission · doi:10.1007/s00702-006-0440-7 · Cited by 26
Zhang, M., Ballard, M. E., Kohlhaas, K. L., Browman, K. E., Jongen-Rêlo, A.-L., Unger, L., Fox, G. B., Groß, G., Decker, M. W., Drescher, K. U., et al. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300985 · Cited by 26
Klamer, D., P�lsson, E., Fejgin, K., Zhang, J., Engel, J. A., & Svensson, L. (2004) · Psychopharmacology · doi:10.1007/s00213-004-2051-z · Cited by 26
Peleg‐Raibstein, D., Sydekum, E., Russig, H. D., & Feldon, J. (2005) · Journal of Neural Transmission · doi:10.1007/s00702-005-0390-5 · Cited by 26
Test–retest reliability of the somatosensory blink reflex and its inhibition
Flaten, M. A. (2002) · International Journal of Psychophysiology · doi:10.1016/s0167-8760(02)00034-x · Cited by 26
Weak prepulses inhibit but do not elicit startle in rats and humans
Swerdlow, N. R., Talledo, J., Shoemaker, J. M., Codon, K., Goins, J., & Auerbach, P. P. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.02.030 · Cited by 25
Self-citation
Flagged first, then by citations
Research works printed but not linked: 9
- American Psychiatric Association (APA) (2000) Diagnostic and Statistical Manual of Mental Disorders DSM-IV-TR Fourth Edition (Text Revision)
- Braff et al (2008) One-year longitudinal study of 200 schizophrenia patients: no clinical, cognitive, neurophysiological or functional differences at intake in retested vs. non-retested patients. Abstr Society for Neuroscience (in press)
- Butler RW, Jenkins MA, Geyer MA, Braff D (1991) Wisconsin card sorting deficits and diminished sensorimotor gating in a discrete subgroup of schizophrenic patients. In: Tamminga CA, Schulz SC (eds) Advances in neuropsychiatry and psychopharmacology. New York, NY: Raven Press, pp 163–168
- Light GA et al (2007a) One year stability of neurophysiological and cognitive endophenotypes of schizophrenia. Proc Am Col Neuropsychopharmacology (in press)
- Light GA et al (2008) Preattentive sensory processing is associated with cognitive and psychosocial functioning in healthy adults. J Cog Neurosci 7:120–128
- Swerdlow NR (1996) Cortico–striatal substrates of cognitive, motor and sensory gating: Speculations and implications for psychological function and dysfunction. In: Panksepp J (ed) Advances in biological psychiatry, vol. 2. JAI Press Inc, Greenwich CT, pp 179–208
- Swerdlow NR et al (2003d) Prestimulus modification of the startle reflex: relationship to personality and physiological markers of dopamine function. Biol Psychology 62:17–26 · DOI
- Swerdlow NR et al (2005a) Effects of memantine on startle gating in normal adult men. Proc Am Coll Neuropsychopharm, Waikoloa, HI
- Swerdlow NR et al (2006g) The “low gating” phenotype in rats: antipsychotic sensitivity, heritability and sex differences. Biol Psychiatry 59:220S
Cited by
Sorted by citations
Animal models of neuropsychiatric disorders
Nestler, E. J., & Hyman, S. E. (2010) · Nature Neuroscience · doi:10.1038/nn.2647 · Cited by 2,023
Dichter, G. S., Damiano, C. A., & Allen, J. A. (2012) · Journal of Neurodevelopmental Disorders · doi:10.1186/1866-1955-4-19 · Cited by 299
Prepulse inhibition and genetic mouse models of schizophrenia
Powell, S. B., Zhou, X., & Geyer, M. A. (2009) · Behavioural Brain Research · doi:10.1016/j.bbr.2009.04.021 · Cited by 218
Ketamine disinhibits dendrites and enhances calcium signals in prefrontal dendritic spines
Ali, F., Gerhard, D. M., Sweasy, K., Pothula, S., Pittenger, C., Duman, R. S., & Kwan, A. C. (2020) · Nature Communications · doi:10.1038/s41467-019-13809-8 · Cited by 196
Milekic, M. H., Xin, Y., O’Donnell, A., Kumar, K. K., Bradley-Moore, M., Malaspina, D., Moore, H., Brunner, D., Ge, Y., Edwards, J., et al. (2015) · Molecular Psychiatry · doi:10.1038/mp.2014.84 · Cited by 190
Metadata
- Authors
- Swerdlow, N. R., Weber, M., Qu, Y., Light, G. A., & Braff, D. L.
- Affiliations
- University of California San Diego (US)
- Corresponding author
- Swerdlow, Neal R.
- Venue
- Psychopharmacology
- Published
- 2008-06-21
- Volume
- 199
- Issue
- 3
- Pages
- 331-388
- ISSN
- 0033-3158 (ISSN-L)
- 1432-2072
- PMC
- PMC2771731
- OpenAlex
- W2062472783
- Cited by
- 529
- References
- 478
- Citations by year
- 2026: 8 · 2025: 14 · 2024: 13 · 2023: 18 · 2022: 19 · 2021: 23 · 2020: 31 · 2019: 21 · 2018: 23 · 2017: 30 · 2016: 38 · 2015: 42 · 2014: 31 · 2013: 51 · 2012: 38
- FWCI
- 5.46
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Psychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Pfizer
- National Alliance for Research on Schizophrenia and Depression
- ACADIA Pharmaceuticals
- Allergan
- Pfizer Pharmaceuticals
- National Institute of Mental Health (MH 53484, MH68366, R01MH069589, MH65571, MH69589, MH42228, R01MH068366, R37MH042228, R01MH053484, R01MH042228, R01MH059803, MH 79777, MH 58903, R01MH065571, R01MH079777)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- prepulse inhibition, schizophrenia, sensorimotor gating, translational model, animal models of schizophrenia, startle response, inhibition mechanism, preclinical drug screening, quantitative phenotypes, model organisms
- MeSH terms
- Animals, Disease Models, Animal, Humans, Models, Psychological, Schizophrenia, Schizophrenic Psychology, Reflex, Startle, Antipsychotic Agents
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review